WealthCollab’s Ascendis Pharma A/S ASND Stock Holding History

WealthCollab’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$801	Buy	+3	New	+$701	﹤0.01%	924
2026 Q1	–	Sell	-3	Closed	-$640	–	979
2025 Q4	$640	Hold	3	–	–	﹤0.01%	982
2025 Q3	$597	Hold	3	–	–	﹤0.01%	949
2025 Q2	$518	Hold	3	–	–	﹤0.01%	924
2025 Q1	$468	Buy	+3	New	+$429	﹤0.01%	883

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

WealthCollab's ASND Position: Q2 2026 in Review

WealthCollab opened a new position in Ascendis Pharma A/S (ASND) in Q2 2026: 3 shares worth $801. The stake represents ﹤0.01% of the portfolio and ranks #924 among its holdings. This is a return to the name: WealthCollab previously reported a position in ASND as recently as Q4 2025.

WealthCollab first reported a position in ASND in Q1 2025 and has held it in 5 quarters since. 313 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

WealthCollab held 3 shares of Ascendis Pharma A/S worth $801 as of Q2 2026.
Ascendis Pharma A/S was a new WealthCollab position in Q2 2026.
Ascendis Pharma A/S made up ﹤0.01% of WealthCollab's portfolio in Q2 2026, its #924 holding.
WealthCollab first reported a position in Ascendis Pharma A/S in Q1 2025 and has held it in 5 quarters since.
313 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on WealthCollab's 13F filing for Q2 2026, filed 10 Aug 2026.